Technology | Fusion Imaging Software | January 03, 2017

MIM Symphony MRI Fusion Biopsy Software Integrates With BK3000 Ultrasound System

New bkFusion solution will allow more accurate and reliable biopsy results than ultrasound-only transrectal biopsy

MIM Software, BK Ultrasound, bkFusion, MRI Fusion Biopsy System, prostate cancer, RSNA 2016

January 3, 2017 —  MIM Software Inc. announced in November the commercial introduction of its MRI (magnetic resonance imaging) Prostate Fusion Software as a fully integrated software on BK Ultrasound’s premium bk3000 ultrasound system. The global launch of this solution for prostate biopsy, bkFusion, was developed in partnership between the companies.

bkFusion is built on MIM Software’s multi-modality image fusion capabilities. In creating bkFusion, MIM Software leveraged its patented Predictive Fusion technology for MRI prostate fusion during biopsy. Predictive Fusion “reslices” and pre-aligns the MRI images to correspond to the prostate’s orientation during the biopsy and then fuses them to the ultrasound images at the time of biopsy, saving time during the procedure. This advancement in MRI targeting assists the practitioner in achieving a higher prostate cancer detection rate when compared to traditional ultrasound-only transrectal biopsy. Patients will benefit from a more accurate and reliable biopsy when prostate cancer is present.

The bkFusion solution, consisting of the bk3000 ultrasound system along with the E14C4t Prostate Triplane transducer, will provide an MRI Fusion Biopsy System with the smallest footprint in the industry, according to the companies. The bk3000 fits easily into any office space and because bkFusion is completely integrated on the ultrasound system, no additional bulky equipment or setup time is required. The system communicates easily with radiology departments, accessing the MRI images via picture archiving and communication system (PACS) or a secure cloud platform. Alternatively, with the BK Flex Focus ultrasound product line, BK Ultrasound will offer a laptop-based bkFusion application. Both the integrated application and laptop version will provide the same user interface, workflow and reporting.

MIM will continue to develop and distribute its MIM Symphony Dx advanced MRI prostate visualization and analysis software for radiologists. Software features include prostate MRI review, linking, contouring and reporting capabilities. MIM Symphony Dx includes tools for quantitative longitudinal analysis, linking of biopsy results and locations with MR, and sophisticated reporting. MIM Symphony Dx and bkFusion share a common platform and will allow seamless communication either directly, via MIMcloud, or through external drives.

BK Ultrasound will distribute bkFusion for use with its bk3000 and Flex Focus ultrasound systems in the United States. BK Ultrasound has undertaken registration globally and will distribute the solutions through its global network.

For more information: www.mimsoftware.com

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Hyperfine Research, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the world’s first bedside Magnetic Resonance Imaging (MRI) system

Hyperfine's point-of-care MRI wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled via a wireless tablet. Photo courtesy of Business Wire

News | Magnetic Resonance Imaging (MRI) | February 12, 2020
February 12, 2020 — Hyperfine Research, Inc. announced that i
The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly

Image courtesy of GE Healthcare

News | Magnetic Resonance Imaging (MRI) | February 11, 2020
February 11, 2020 — The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly in the fo
Gadolinium-based contrast agents

UT Dallas faculty members who collaborated with Dr. Jeremiah Gassensmith (center, back), associate professor of chemistry and biochemistry, include Dr. Lloyd Lumata (left, back), assistant professor of physics, and Dr. Steven Nielsen, associate professor of chemistry. Chemistry graduate students in Gassensmith’s lab include (from left, front) Oliva Brohlin, Arezoo Shahrivarkevishahi and Laurel Hagge.

News | Contrast Media | February 06, 2020
February 6, 2020 — University of Texas at Dallas researchers
Qynapse, a medical technology company, announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its QyScore software
News | Information Technology | February 04, 2020
February 4, 2020 — Qynapse, a medical technology company, anno
RSNA 2019

RSNA 2019

Feature | Radiology Imaging | January 31, 2020 | By Greg Freiherr
The founder of Gonzo journalism thought
This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma

This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma. The quarter dose image on the left was obtained after the administration of 4 ml of MultiHance. Subsequently, an additional 12 ml of MultiHance was administered and the cumulative full dose image in the center was obtained. The image on the right was rendered following artificial intelligence processing of the 4 ml image using eGad genetic algorithms. This image has the quality of triple dose gadolinium even though only one quarter dose gadolinium was given.

Feature | Contrast Media Injectors | January 30, 2020 | By Matthew Kuhn, M.D., FACR
Gadolinium-based contrast agents (...
Automated Triage of Thyroid Cancer

73-year-old man with papillary carcinoma of left lobe of thyroid. Screen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electronic Physician Annotation Device software (Stanford Medicine Radiology). Radiologists performed nodule segmentation by selecting points (red) on nodule outline (green), while controlling smoothing of outline polygon by means of spline interpolation.

News | Ultrasound Imaging | January 30, 2020
January 30, 2020 — According to an ar...
The researchers used high resolution cross-sectional imaging with CT or MRI to assess 225 men with abdominal aortic aneurysm. Follow-up lasted, on average, more than three years.  Slightly more than half of patients had an intraluminal thrombus. The aneurysms of those with intraluminal thrombus were larger at baseline and grew by a rate of 2 mm per year, twice as fast as the 1 mm per year growth rate in people without intraluminal thrombus.
News | Computed Tomography (CT) | January 29, 2020
January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...